Introduction
Neonatal atrial flutter (AFL) has a usually benign clinical course in patients with normal structural hearts. However, an AFL can be potentially lethal in cases of recurrent attack and can result in complications, such as congestive heart failure.
Moreover, an intractable AFL requires multiple external electrical cardioversions, and it demonstrates a poor response to antiarrhythmic drug therapy [1] [2] [3] . Here, we report a case of intractable AFL which was successfully controlled with flecainide and propranolol therapy in a premature infant.
Case
A 1-month-old premature infant was referred to Kangdong Sacred Heart Hospital (Seoul) because of an irregular heart beat with irritability. He was born at 34 weeks' gestation with a birth weight of 2.07 kg. There was history of maternal gestational diabetes. At birth, the infant had a history of a small perimembranous ventricular septal defect. A baseline surface electrocardiogram revealed a frequent atrial premature complex (APC) with intermittent non-conduction and aberrant conduction ( Fig. 1) Although Atrial flutter (AFL) in newborn infant with normal cardiac anatomy has benign clinical course, an intractable AFL is associated with an increased risk of development of heart failure and sudden death, and is still difficult to manage. It requires multiple external electrical cardioversions, and it shows a poor response to antiarrhythmic drug therapy. We report a case of a premature infant with an intractable AFL, which we successfully treated with oral flecainide and propranolol in spite of recurred AFL. A 1-month-old, 34-week gestation, premature baby presented with an irregular heart beat and irritability. An AFL with 2:1 atrioventricular conduction was documented. Because of the intractable AFL, repeated electrical cardioversion and amiodarone were continued for 14 days. However, amiodarone was discontinued in favour of flecainide and propranolol because of the recurrent AFL and newly developed transient hypothyroidism. During 1-year follow-up period, in which oral flecainide and propranolol were continued, no AFL was observed. Prior studies have shown that electrical cardioversion and intravenous use of antiarrhythmic drugs therapy, such as amiodarone, propafenone, and flecainide, are usually the most effective therapy for the acute termination of neonatal AFL [4, 5] . Only a few case reports have investigated using antiarrhythmic drug therapy to treat intractable AFL in a premature baby [6, 7] . Flecainide is a class IC antiarrhythmic drug that act primarily slows conduction by depressing the maximum rate of the rise of depolarization of the action potential with minimal prolongation of refractoriness. And propranolol is a non-selective beta blocker with atrioventricular node blocking. Perhaps the flecainide and propranolol helped suppress these. There is much good evidence that oral combination therapy with a class IC antiarrhythmic drug combined with a beta blocker is effective at suppressing intractable AFL in a premature infant. To our knowledge, in the literature, there are no case reports in which a premature infant was successfully treated with oral flecainide and propranolol without any proarrhythmic side effects. Therefore, these combination therapies may be considered to an effective therapy in this special clinical setting.
